NRXS
Price
$3.02
Change
+$0.27 (+9.82%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
27.15M
59 days until earnings call
PTIX
Price
$4.30
Change
+$0.06 (+1.42%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
8.12M
Interact to see
Advertisement

NRXS vs PTIX

Header iconNRXS vs PTIX Comparison
Open Charts NRXS vs PTIXBanner chart's image
Neuraxis
Price$3.02
Change+$0.27 (+9.82%)
Volume$100
Capitalization27.15M
Protagenic Therapeutics
Price$4.30
Change+$0.06 (+1.42%)
Volume$473
Capitalization8.12M
NRXS vs PTIX Comparison Chart in %
Loading...
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRXS vs. PTIX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXS is a Buy and PTIX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (NRXS: $2.75 vs. PTIX: $4.24)
Brand notoriety: NRXS and PTIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXS: 77% vs. PTIX: 4%
Market capitalization -- NRXS: $27.15M vs. PTIX: $8.12M
NRXS [@Biotechnology] is valued at $27.15M. PTIX’s [@Biotechnology] market capitalization is $8.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXS’s FA Score shows that 0 FA rating(s) are green whilePTIX’s FA Score has 1 green FA rating(s).

  • NRXS’s FA Score: 0 green, 5 red.
  • PTIX’s FA Score: 1 green, 4 red.
According to our system of comparison, NRXS is a better buy in the long-term than PTIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXS’s TA Score shows that 6 TA indicator(s) are bullish while PTIX’s TA Score has 5 bullish TA indicator(s).

  • NRXS’s TA Score: 6 bullish, 3 bearish.
  • PTIX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NRXS is a better buy in the short-term than PTIX.

Price Growth

NRXS (@Biotechnology) experienced а +5.36% price change this week, while PTIX (@Biotechnology) price change was +10.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +9.43%, and the average quarterly price growth was +55.19%.

Reported Earning Dates

NRXS is expected to report earnings on Nov 24, 2025.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRXS($27.2M) has a higher market cap than PTIX($8.12M). NRXS YTD gains are higher at: 28.319 vs. PTIX (-37.318). PTIX has higher annual earnings (EBITDA): -5.18M vs. NRXS (-7.01M). NRXS has more cash in the bank: 5.99M vs. PTIX (873K). NRXS (410K) and PTIX (420K) have identical debt. NRXS has higher revenues than PTIX: NRXS (3.22M) vs PTIX (0).
NRXSPTIXNRXS / PTIX
Capitalization27.2M8.12M335%
EBITDA-7.01M-5.18M135%
Gain YTD28.319-37.318-76%
P/E RatioN/AN/A-
Revenue3.22M0-
Total Cash5.99M873K686%
Total Debt410K420K98%
FUNDAMENTALS RATINGS
PTIX: Fundamental Ratings
PTIX
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRXSPTIX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 5 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBY76.141.95
+2.64%
Best Buy Company
DOMH6.840.13
+1.94%
Dominari Holdings
LOBO0.65N/A
+0.03%
LOBO EV TECHNOLOGIES Ltd
FMNB14.51-0.09
-0.62%
Farmers National Banc Corp
DKL45.50-0.50
-1.09%
Delek Logistics Partners LP

NRXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
+9.65%
CVM - NRXS
59%
Loosely correlated
+5.16%
PTIX - NRXS
45%
Loosely correlated
+1.42%
ARMP - NRXS
38%
Loosely correlated
-0.34%
TNGX - NRXS
29%
Poorly correlated
+7.03%
BTAI - NRXS
27%
Poorly correlated
-3.72%
More

PTIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTIX has been loosely correlated with NRXS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PTIX jumps, then NRXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTIX
1D Price
Change %
PTIX100%
+1.42%
NRXS - PTIX
45%
Loosely correlated
+9.65%
ARMP - PTIX
41%
Loosely correlated
-0.34%
TNGX - PTIX
27%
Poorly correlated
+7.03%
CTXR - PTIX
26%
Poorly correlated
-0.87%
BPTSY - PTIX
24%
Poorly correlated
N/A
More